Correlation Between Mangoceuticals, Common and EUDA Health

Can any of the company-specific risk be diversified away by investing in both Mangoceuticals, Common and EUDA Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mangoceuticals, Common and EUDA Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mangoceuticals, Common Stock and EUDA Health Holdings, you can compare the effects of market volatilities on Mangoceuticals, Common and EUDA Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mangoceuticals, Common with a short position of EUDA Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mangoceuticals, Common and EUDA Health.

Diversification Opportunities for Mangoceuticals, Common and EUDA Health

-0.54

Correlation Coefficient

Mangoceuticals, Common  EUDA Health

Excellent diversification

The 3 months correlation between Mangoceuticals, and EUDA is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Mangoceuticals, Common Stock and EUDA Health Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EUDA Health Holdings and Mangoceuticals, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mangoceuticals, Common Stock are associated (or correlated) with EUDA Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EUDA Health Holdings has no effect on the direction of Mangoceuticals, Common i.e., Mangoceuticals, Common and EUDA Health go up and down completely randomly.

Pair Corralation between Mangoceuticals, Common and EUDA Health

Given the investment horizon of 90 days Mangoceuticals, Common Stock is expected to under-perform the EUDA Health. But the stock apears to be less risky and, when comparing its historical volatility, Mangoceuticals, Common Stock is 1.11 times less risky than EUDA Health. The stock trades about -0.11 of its potential returns per unit of risk. The EUDA Health Holdings is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  456.00  in EUDA Health Holdings on August 31, 2024 and sell it today you would lose (24.00) from holding EUDA Health Holdings or give up 5.26% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Mangoceuticals, Common Stock  vs.  EUDA Health Holdings

Mangoceuticals, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mangoceuticals, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

EUDA Health Holdings

Risk-Adjusted Performance

1 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in EUDA Health Holdings are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent fundamental indicators, EUDA Health may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Mangoceuticals, Common and EUDA Health

The main advantage of trading using opposite Mangoceuticals, Common and EUDA Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mangoceuticals, Common position performs unexpectedly, EUDA Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EUDA Health will offset losses from the drop in EUDA Health's long position.

The idea behind Mangoceuticals, Common Stock and EUDA Health Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.